Want to see IN:BALPHARMA full AI Analyst Report?
Bal Pharma Limited (BALPHARMA) Financial Statements
Bal Pharma Limited Financial Overview
Bal Pharma Limited's market cap is currently $1.29B. The company's EPS TTM is $4.54; its P/E ratio is 18.03; and it has a dividend yield of 1.47%. Bal Pharma Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.12B | $ 3.03B | $ 3.39B | $ 3.04B | $ 2.81B |
| Gross Profit | $ 761.52M | $ 730.18M | $ 770.20M | $ 1.25B | $ 1.11B |
| Operating Income | $ 208.24M | $ 197.89M | $ 214.57M | $ 177.23M | $ 149.18M |
| EBITDA | $ 338.31M | $ 317.63M | $ 320.23M | $ 245.00M | $ 239.71M |
| Net Income | $ 62.84M | $ 72.15M | $ 73.92M | $ 25.72M | $ 56.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 92.92M | $ 105.19M | $ 199.29M | $ 74.63M | $ 60.84M |
| Total Assets | $ 3.76B | $ 3.36B | $ 3.20B | $ 3.13B | $ 2.61B |
| Total Debt | $ 1.60B | $ 1.50B | $ 1.42B | $ 1.33B | $ 1.07B |
| Net Debt | $ 1.52B | $ 1.42B | $ 1.38B | $ 1.30B | $ 1.06B |
| Total Liabilities | $ 2.93B | $ 2.58B | $ 2.50B | $ 2.49B | $ 2.02B |
| Stockholders' Equity | $ 822.27M | $ 774.16M | $ 692.94M | $ 637.89M | $ 586.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -40.83M | $ -145.55M | $ 118.26M | $ -164.89M | $ 192.39M |
| Operating Cash Flow | $ 144.72M | $ 42.32M | $ 228.06M | $ -18.43M | $ 277.08M |
| Investing Cash Flow | $ -215.41M | $ -156.53M | $ -188.91M | $ -221.82M | $ -94.85M |
| Financing Cash Flow | $ 72.26M | $ 90.12M | $ -12.06M | $ 244.00M | $ -181.34M |
Currency in INR